Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: AltaRex (AEX.ASE)

No earlier versions found for this Subject.

Return to AltaRex (AEX.ASE)

AltaRex ----> AEX.ASE @ $1.75 - $1.83

Dr. A. Noujaim, President and CEO of AltaRex was President and CEO of BIOMIRA (also once under $2.00 before hitting $30).

This is a cancer research company that has developed an Ovarian Cancer Vaccine (OVAREX) and currently has just recieved approval for phase II/III trials in Canada and Europe.

"AltaRex focuses on the development and discovery of products for the treatment and diagnosis of Cancer. These products are basedon AltaRex's platform technology which is known as Anti-idiotype Induction Therapy (``AIT(TM)''). AIT(TM) is based on the ability of the human immune system to respond, when stimulated, to the presence of a tumour. AltaRex also has products for the treatment of breast and colorectal cancer in pre-clinical development."

Anyone else follow this company?

Sam.